Literature DB >> 23204219

The risky business of studying prognosis.

Lily Siok Hoon Lim1, Brian M Feldman.   

Abstract

Prognosis studies provide important healthcare information. Clinicians use prognostic factors to predict disease progress, thus allowing individualization of disease management. Prognosis is the issue in many translational studies that aim to identify biomarkers to predict outcomes. In a clinical trial, researchers may use prognostic factors to sort patients into risk groups, to clarify the effects of a new therapeutic agent. Prognosis studies can have significant effects on clinical practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23204219     DOI: 10.3899/jrheum.121360

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  1 in total

1.  Commentary on "The risky business of studying prognosis".

Authors:  Anna Broder; Chaim Putterman
Journal:  J Rheumatol       Date:  2013-10       Impact factor: 4.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.